BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30043645)

  • 1. A systematic analysis of the association between Notch1 expression and the patients with digestive tract cancers.
    Zhang W; Chen H; Sun Z; Qiu C; Xiao J; Luo W; Liu D; Yan Z; Ou H; Wen X; Li G; Huang G
    Biomark Med; 2018 Sep; 12(9):1049-1062. PubMed ID: 30043645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression profile and clinicopathological significance of Notch1 in patients with colorectal cancer: a meta-analysis.
    Li G; Zhou Z; Zhou H; Zhao L; Chen D; Chen H; Zou H; Qi Y; Jia W; Pang L
    Future Oncol; 2017 Oct; 13(23):2103-2118. PubMed ID: 28984154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation of the CHFR gene in digestive tract cancer.
    Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
    Anticancer Res; 2006; 26(3A):1791-5. PubMed ID: 16827108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CARD6, an NF-kappaB activator, in gastric, colorectal and oesophageal cancers.
    Kim SS; Ahn CH; Kang MR; Kim YR; Kim HS; Yoo NJ; Lee SH
    Pathology; 2010 Jan; 42(1):50-3. PubMed ID: 20025480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
    Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL
    Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value.
    Ren C; Chen H; Han C; Fu D; Zhou L; Jin G; Wang F; Wang D; Chen Y; Ma L; Zheng X; Han D
    Oncotarget; 2016 Mar; 7(13):15840-53. PubMed ID: 26895105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.
    Mukai S; Oue N; Oshima T; Mukai R; Tatsumoto Y; Sakamoto N; Sentani K; Tanabe K; Egi H; Hinoi T; Ohdan H; Yasui W
    Ann Surg Oncol; 2017 Feb; 24(2):594-602. PubMed ID: 26832883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOTCH1 expression predicts patient prognosis in esophageal squamous cell cancer.
    Ogawa R; Ishiguro H; Kimura M; Funahashi H; Wakasugi T; Ando T; Shiozaki M; Takeyama H
    Eur Surg Res; 2013; 51(3-4):101-7. PubMed ID: 24217574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of circulating microRNA-21 expression in esophageal, pancreatic and colorectal cancers; a systematic review and meta-analysis.
    Guraya S
    Int J Surg; 2018 Dec; 60():41-47. PubMed ID: 30336280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of PLCE1 expression in upper gastrointestinal cancer: a systematic review and meta-analysis.
    Cui XB; Peng H; Li S; Li TT; Liu CX; Zhang SM; Jin TT; Hu JM; Jiang JF; Liang WH; Li N; Li L; Chen YZ; Li F
    Asian Pac J Cancer Prev; 2014; 15(22):9661-6. PubMed ID: 25520085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
    Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z
    BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions.
    Chen YT; Panarelli NC; Piotti KC; Yantiss RK
    Cancer Immunol Res; 2014 May; 2(5):480-6. PubMed ID: 24795360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparity expression of Notch1 in benign and malignant colorectal diseases.
    Huang R; Tang Q; You Q; Liu Z; Wang G; Chen Y; Sun Y; Muhammad S; Wang X
    PLoS One; 2013; 8(12):e81005. PubMed ID: 24312514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations of mitochondrial DNA in digestive tract cancers.
    Kose K; Hiyama T; Tanaka S; Yoshihara M; Yasui W; Chayama K
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1679-84. PubMed ID: 16246185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The notch pathway is activated in neoplastic progression in esophageal squamous cell carcinoma.
    Lubin DJ; Mick R; Shroff SG; Stashek K; Furth EE
    Hum Pathol; 2018 Feb; 72():66-70. PubMed ID: 29137934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F806 Suppresses the Invasion and Metastasis of Esophageal Squamous Cell Carcinoma via Downregulating F-Actin Assembly-Related Rho Family Proteins.
    Xie L; Li LY; Zheng D; Xie YM; Xu XE; Tao LH; Liao LD; Xie YH; Cheng YW; Xu LY; Li EM
    Biomed Res Int; 2018; 2018():2049313. PubMed ID: 30327774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expressions of Notch signaling-associated proteins in esophageal squamous cell carcinoma].
    Yuan Y; Hu Y; Zhao Y; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):909-13. PubMed ID: 26404689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of Sox2 expression in digestive tract cancers: A meta-analysis.
    Du XM; Wang LH; Chen XW; Li YX; Li YC; Cao YW
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):305-312. PubMed ID: 27376796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.